Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy

被引:0
|
作者
Shohei Takaichi
Yoshito Tomimaru
Shogo Kobayashi
Keisuke Toya
Kazuki Sasaki
Yoshifumi Iwagami
Daisaku Yamada
Takehiro Noda
Hidenori Takahashi
Tadafumi Asaoka
Masahiro Tanemura
Yuichiro Doki
Hidetoshi Eguchi
机构
[1] Osaka University Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Osaka Police Hospital,Department of Surgery
[3] Rinku General Medical Center,Department of Surgery
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2458 / 2468
页数:10
相关论文
共 50 条
  • [1] ASO Visual Abstract: Change Impact of Body Composition during Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy
    Takaichi, Shohei
    Tomimaru, Yoshito
    Kobayashi, Shogo
    Toya, Keisuke
    Sasaki, Kazuki
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Noda, Takehiro
    Takahashi, Hidenori
    Asaoka, Tadafumi
    Tanemura, Masahiro
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2471 - 2472
  • [2] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [3] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Yuki Homma
    Koichi Taniguchi
    Takashi Murakami
    Kazuya Nakagawa
    Masatoshi Nakazawa
    Ryusei Matsuyama
    Ryutaro Mori
    Kazuhisa Takeda
    Michio Ueda
    Yasushi Ichikawa
    Kuniya Tanaka
    Itaru Endo
    [J]. Annals of Surgical Oncology, 2014, 21 : 670 - 676
  • [4] ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes
    Shohei Takaichi
    Yoshito Tomimaru
    Shogo Kobayashi
    Keisuke Toya
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Takehiro Noda
    Hidenori Takahashi
    Tadafumi Asaoka
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    [J]. Annals of Surgical Oncology, 2023, 30 : 2469 - 2470
  • [5] ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes
    Takaichi, Shohei
    Tomimaru, Yoshito
    Kobayashi, Shogo
    Toya, Keisuke
    Sasaki, Kazuki
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Noda, Takehiro
    Takahashi, Hidenori
    Asaoka, Tadafumi
    Tanemura, Masahiro
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2469 - 2470
  • [6] Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Kumamoto, Kensuke
    Suzuki, Yasuyuki
    Okano, Keiichi
    [J]. HPB, 2023, 25 (01) : 136 - 145
  • [7] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    [J]. PANCREATOLOGY, 2023, 23 (04) : 367 - 376
  • [8] ANALYSIS OF RECURRENCE FOLLOWING POST-NEOADJUVANT PANCREATECTOMY IN RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
    Maggino, Laura
    Malleo, Giuseppe
    Crippa, Stefano
    Belfiori, Giulio
    Nobile, Sara
    Gasparini, Giulia
    Lionetto, Gabriella
    Bassi, Claudio
    Falconi, Massimo
    Salvia, Roberto
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1359 - S1359
  • [9] Predictors of Undergoing Surgical Resection after Neoadjuvant Chemoradiotherapy for Borderline Resectable and Resectable Pancreatic Adenocarcinoma
    Neibart, S. S.
    Mamidanna, S.
    Chundury, A.
    Sayan, M.
    Alexander, H. R.
    August, D.
    Berim, L. D.
    Boland, P. M.
    Grandhi, M. S.
    Gulhati, P.
    Kennedy, T. J.
    Langan, R. C.
    Spencer, K.
    Jabbour, S. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E63 - E64
  • [10] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    [J]. DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461